ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

Two ISPE Studies were cited in FDA statement to Congress.

Print | 
Email |  Comment   Share  
December 30, 2013 - In her statement associated with her testimony to U.S. Congressional Committee on Oversight and Government Reform's Subcommittee on Energy Policy, Health Care, and Entitlements, Janet Woodcock cited 2 ISPE studies – survey conducted by ISPE UK Affiliate's Process Analytical Technology (PAT) Community of Practice, and Drug Shortages Survey report – to advocate use of Quality by Design (QbD) to enhance development capability and reduce manufacturing costs while ensuring quality drug products.

Two ISPE Studies Cited in FDA Statement to Congress


ISPE
600 N. Westshore Blvd., Suite 900
Tampa, FL, 33609
USA



Press release date: December 20, 2013

(TAMPA, FLORIDA, USA) – Two recent ISPE studies were cited by Janet Woodcock, M.D., Director of the US FDA’s Center for Drug Evaluation and Research (CDER), in her statement associated with her testimony to the U.S. Congressional Committee on Oversight and Government Reform’s Subcommittee on Energy Policy, Health Care and Entitlements.

In the December 12 hearing, “FDA Check Up: Drug Development and Manufacturing Challenges,” Dr. Woodcock stated that novel manufacturing technologies could, with the proper strategies, revitalize pharmaceutical manufacturing in the U.S., thereby reducing dependence on potentially vulnerable foreign-sourced materials.  Dr. Woodcock reported that the FDA has been working in collaboration with industry experts to stimulate the development of new manufacturing technologies capable of responding rapidly to changes in demand.

During her testimony Dr. Woodcock strongly advocated the use of Quality by Design (QbD) to enhance development capability and reduce manufacturing costs while ensuring that patients receive high-quality drug products.  As evidence, Dr. Woodcock cited the results of a survey conducted by the ISPE United Kingdom Affiliate’s Process Analytical Technology (PAT) Community of Practice, in which companies using QbD reported benefits such as improved product quality and process robustness, increased process capability, greater speed and reliability to market, as well as significant cost benefits.

QbD also can increase manufacturing capability and a firm’s ability to identify the root causes of manufacturing failures, said Dr. Woodcock, referencing ISPE’s Drug Shortages study and naming inadequate manufacturing capability as a frequent cause of critical drug supply shortfalls, particularly in the areas of lyophilization (freeze-drying) associated with the production of sterile products.

“We applaud the FDA’s collaborative approach to the development of new manufacturing technologies as a means of ensuring the availability of safe and effective medicines,” said Nancy S. Berg, President and CEO of ISPE.  “The development and adoption of new and novel manufacturing technologies such as continuous manufacturing requires close collaboration and communication between the pharmaceutical industry and global regulators. As a neutral organization focused on product quality important to patient safety, we are pleased to provide the FDA with reliable, authoritative, scientific technical data and experience. We look forward to continued collaboration with the FDA to modernize manufacturing methods.”

Published in June 2013, ISPE’s Drug Shortages Survey report is available at www.ISPE.org/Drug-Shortages/2013JuneReport. The report also was cited in the FDA’s Strategic Plan for Preventing and Mitigating Drug Shortages published in October. ISPE plans to deliver additional updates during 2014.

A summary of the Business Benefits of Quality by Design (QbD) survey conducted by the ISPE United Kingdom Affiliate’s PAT Community of Practice was published in the July-August 2012 issue of Pharmaceutical Engineering magazine.
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
More .....
 See more product news in:
Services
 More New Product News from this company:
Educational Sessions/Workshops highlight ISPE conference.
More ....
| Featured Manufacturing Jobs
 Other News from this company:
Southeast's Largest Annual Gathering of Life Science Professionals
Find Smart Solutions for Lifecycle Innovation at Pharma EXPO Debut
FDA's Thomas Arista and Rick Friedman Confirmed as Keynote Speakers at 23rd Annual ISPE Aseptic Conference
ISPE Marks 10-Year Anniversary of Its Facility of the Year Awards Program
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Trade Associations


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address